[Innovative forms of specific immunotherapy]. - Wikidata - wikimedia - TriplyDB

[Innovative forms of specific immunotherapy].

[Innovative forms of specific immunotherapy].

http://www.wikidata.org/entity/Q53505747

about

[Innovative forms of specific immunotherapy].

http://www.wikidata.org/entity/Q53505747

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

[Innovative forms of specific immunotherapy].

@en

[Innovative forms of specific immunotherapy].

@nl

type

label

[Innovative forms of specific immunotherapy].

@en

[Innovative forms of specific immunotherapy].

@nl

prefLabel

[Innovative forms of specific immunotherapy].

@en

[Innovative forms of specific immunotherapy].

@nl

P1433

Q53505747-60E4546E-2A71-4424-B3DC-57C2CA487D64

P1476

Q53505747-82DF7817-6883-4515-A972-AC999DA43400

P2093

Q53505747-04625CDD-BD63-4030-A807-123D64AD3C2A

P2860

Q53505747-070343F6-8BE0-464A-BC70-F5EBFFE543FC

Q53505747-088A91F4-6434-4249-A09D-54A4D41ABB90

Q53505747-26BA17D6-2492-47C2-9E43-02931E42D628

Q53505747-4567C38E-28F3-45E2-99BF-65366EC139F4

Q53505747-4BE4A347-4A1E-415D-9F70-AA4433523607

Q53505747-60AB3CC0-98DB-45E1-80AF-41C9579543E4

Q53505747-69D2F496-247D-4C2D-9FFB-BA674F577553

Q53505747-6B06C9B8-B92A-48E5-B47C-EFEE04D7E4F3

Q53505747-78042BA4-515E-41C9-9E87-C73FE4E95AB1

Q53505747-918D557C-90BA-4022-BD44-07A9113D6C3D

P2888

Q53505747-3AB3A2AC-DA3E-416E-A79C-DEA89AA7262D

P304

Q53505747-A80C7168-7A7E-4AEB-AC16-CEA26B8C3A34

P31

Q53505747-4A65C566-2A43-48A9-AE0B-FC3D672F90EB

P356

Q53505747-1222FE31-5E46-4E03-989C-DDC1D9EE2DBE

P407

Q53505747-A38EF478-8473-472D-8E87-5757CB98C8CC

P433

Q53505747-89E94E88-015D-4048-B468-DB58DF11ADE1

P478

Q53505747-61C7E878-1E0C-4E52-A3A6-CCE43EA6546F

P577

Q53505747-A4129533-FC58-4DBD-B726-8C023CF1E937

P698

Q53505747-288601AB-471E-449C-BD2B-97EBFEF21F57

P921

Q53505747-6B68AD45-9F0C-4C1C-A6DF-68B67562521B

P356

S00105-017-3948-X

P1433

P1476

[Innovative forms of specific immunotherapy].

@en

P2093

P Zieglmayer

http://www.w3.org/2001/XMLSchema#string

P2860

Active treatment for food allergy

Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5-sensitized mice.

Intralymphatic immunotherapy

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.

Genome-wide association study reveals class I MHC-restricted T cell-associated molecule gene (CRTAM) variants interact with vitamin D levels to affect asthma exacerbations.

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.

Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.

Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides

Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial.

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection

P2888

s00105-017-3948-x

P304

287-291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00105-017-3948-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28197701

http://www.w3.org/2001/XMLSchema#string

P921